Literature DB >> 29023181

Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis.

Ilknur Tugal-Tutkun1, Luca Cimino2, Yonca Aydin Akova3.   

Abstract

Varicella zoster virus (VZV)-induced anterior uveitis (AU) may complicate the course of primary varicella infection typically seen in children. In adults, especially with advanced age, VZV AU is more commonly associated with herpes zoster ophthalmicus (HZO) with or without skin rash affecting the distribution of the ophthalmic nerve due to reactivation of the latent VZV in the trigeminal ganglion. While it is typically a mild self-limiting AU in primary infection, HZO AU is often accompanied by keratitis, may have a chronic recurrent course, and lead to sectoral iris atrophy, pupillary distortion, and ocular hypertension. Diagnosis is often clinical and proven by analysis of aqueous humor for viral genome or antiviral antibodies. Systemic antiviral agents and topical steroids are the mainstay of treatment. Visual prognosis is favorable with timely diagnosis and appropriate treatment.

Entities:  

Keywords:  Antiviral treatment; herpes zoster ophthalmicus; primary varicella infection; varicella zoster virus; viral anterior uveitis; visual prognosis

Mesh:

Substances:

Year:  2017        PMID: 29023181     DOI: 10.1080/09273948.2017.1383447

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  Classification Criteria for Varicella Zoster Virus Anterior Uveitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

Review 2.  Viral anterior uveitis.

Authors:  Kalpana Babu; Vinaya Kumar Konana; Sudha K Ganesh; Gazal Patnaik; Nicole S W Chan; Soon-Phaik Chee; Bianka Sobolewska; Manfred Zierhut
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

3.  Varicella zoster virus anterior uveitis complicated by thalamic stroke.

Authors:  Casey L Anthony; Anastasios P Costarides; Steven Yeh; Jessica G Shantha
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.